HAIFA, Israel and MIAMI, Feb. 5, 2026 /CNW/ — Insightec, a global healthcare company dedicated to using focused ultrasound to transform patient care, today announced it has received a Medical Device License from Health Canada for its Exablate® Prime system. Previously approved by the U.S. Food and Drug Administration (FDA), this approval expands access to incisionless, MR-guided focused ultrasound treatments, providing relief for patients in Canada living with essential tremor.
Read more here.
![[DreaMed in Odessa American] The Helmsley Charitable Trust Awards Clalit Health Services $3.4M to Evaluate Closed-loop AI Technology at Schneider Children’s Medical Center for People Requiring Insulin Injection Therapy](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
